Research programme: alpha 4 beta 7 integrin antagonist - DICE Therapeutics
Alternative Names: Oralα4ß7; α4ß7 Integrin AntagonistLatest Information Update: 11 Aug 2023
At a glance
- Originator DiCE Molecules
- Developer DICE Therapeutics
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Alpha4beta7 integrin antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Inflammatory bowel diseases